How sensitive is safe? Risk-based targets for ambient monitoring of pathogens

IEEE Sensors Journal

Volumn 10, Issue 3, 2010, Pages 668-673

  Huang, Yin ^a   Hong, Tao ^a   Bartrand, Timothy A ^b   Gurian, Patrick L ^a   Haas, Charles N ^a   Liu, Ran ^a   Tamrakar, Sushil B ^a  

^a Drexel University   (United States)

^b Clancy Environmental Consultants Inc   (United States)

Author keywords

Dose response; Microbial risk; Pathogen; Sensor

Indexed keywords

AMBIENT MONITORING; ANTIBIOTIC TREATMENT; BACILLUS ANTHRACIS; BIOLOGICAL AGENTS; CHEMICAL AGENT; COSTS AND BENEFITS; DECISION MODELS; DETECTOR SYSTEMS; DOSE RESPONSE; ENVIRONMENTAL MONITORING SYSTEM; ENVIRONMENTAL SAMPLING; EXPOSURE PERIOD; HUMAN BREATHING; LOW CONCENTRATIONS; MEDICAL TREATMENT; MICROBIAL RISK; ORDER OF MAGNITUDE; ORDERS OF MAGNITUDE; PHASE CONCENTRATION; RISK LEVELS; RISK-BASED; SAMPLING RATES; SENSING SYSTEMS; THRESHOLD LEVELS; YERSINIA PESTIS;

BACTERIOLOGY; PATHOGENS; SAMPLING; SENSITIVITY ANALYSIS; VIRUSES;

SENSORS;

EID: 77649083585     PISSN: 1530437X     EISSN: None     Source Type: Journal    
DOI: 10.1109/JSEN.2009.2038659     Document Type: Article

References (20)

1. A. Sabelnikov, V. Zhukov, and R. Kempf, "Probability of real-time detection versus probability of infection for aerosolized biowarfare agents: A model study," Biosens. Bioelectron., vol. 21, pp. 2070-2077, 2006.
2. B. P. Zietz and H. Dunkelberg, "The history of the plague and the research on the causative agent Yersinia pestis," Int. J. Hyg. Environ. Health, vol. 207, pp. 165-178, 2004.
3. Y. Huang and C. N. Haas, "Time-dose-response models for microbial risk assessment," Risk Anal., vol. 29, no. 5, pp. 648-661, 2009.
4. Y. Huang, T. A. Bartrand, C. N. Haas, and M. H. Weir, "Incorporating time postinoculation into a dose-response model of Yersinia pestis in mice," J. Appl. Microbiol., vol. 107, no. 3, pp. 727-735, 2009.
5. W. R. Byrne, S. L. Welkos, M. L. Pitt, K. J. Davis, R. P. Brueckner, J. W. Ezzell, G. O. Nelson, J. R. Vaccaro, L. C. Battersby, and A. M. Friedlander, "Antibiotic treatment of experimental pneumonic plague in mice," Antimicrob. Agents Chemother., vol. 42, no. 3, pp. 675-681, 1998.
6. L. L. Boulanger, J. D. Fogarty, D. T. Dennis, D. Romig, and G. Mertz, "Gentamicin and tetracyclines for the treatment of human plague: Review of 75 cases in New Mexico, 1985-1999," Clin. Infect. Dis., vol. 38, pp. 663-669, 2004.
7. P. Russell, S. M. Eley, M. Green, A. J. Stagg, R. R. Taylor, M. Nelson, R. J. Beedham, D. L. Bell, D. Rogers, D. Whittington, and R. W. Titball, "Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection," J. Antimicrob. Chemother., vol. 41, pp. 301-305, 1998.
8. W. Mwengee, T. Butler, S. Mgema, G. Mhina, Y. Almasi, C. Bradley, J. B. Formanik, and C. G. Rochester, "Treatment of plague with gen-tamicin or doxycycline in a randomized clinical trial in Tanzania," Clin. Infect. Dis., vol. 42, no. 5, pp. 614-621, 2006.
9. D. C. Keyes, Medical Response to Terrorism: Preparedness and Clinical Practice. Baltimore, MD: Williams & Wilkins, 2004.
10. J. E. Brouillard, C. M. Terriff, A. Tofan, and M. W. Garrison, "Antibiotic selection and resistance issues with fluoroquinolones and doxycy-cline against bioterrorism agents," Pharmacotherapy, vol. 26, no. 1, pp. 3-14, 2006.
11. W. K. Viscusi and J. Aldy, "The value of a statistical life: A critical review of market estimates throughout the world," J. Risk Uncertainty, vol. 27, no. 1, pp. 5-76, 2003.
12. R. A. Fowler, G. D. Sanders, D. M. Bravata, B. Nouri, J. M. Gastwirth, D. Peterson, A. G. Broker, A. M. Garber, and D. K. Owens, "Cost-effectiveness of defending against bioterrorism: A comparison of vaccination and antibiotic prophylaxis against anthrax," Ann. Int. Med., vol. 142, pp. 601-610, 2005.
13. R. S. Speck and H. Wolochow, "Studies on the experimental epidemiology of respiratory infections. VIII. Pnuemonic plague in macacus rhesus," J. Infect. Dis., vol. 100, pp. 58-69, 1957.
14. C. N. Haas, J. B. Rose, and C. P. Gerba, Quantitative Microbial Risk Assessment. New York: Wiley, 1999.
15. P. F. M. Teunis and A. H. Havelaar, "Risk assessment for protozoan parasites," Int. Biodeterior. Biodegrad., vol. 50, pp. 185-193, 2002.
16. R. G. Sextro, D. M. Lorenzetti, M. D. Sohn, and T. L. Thatcher, "Modeling the spread of anthrax in buildings," presented at the Indoor Air 2002 Conf., Monterey, CA.
17. S. B. Tamraker and C. N. Haas, "Dose-response model for lassa virus," Hum. Ecol. Risk, vol. 14, no. 4, pp. 742-752, 2008.
18. T. A. Bartrand, M. H. Weir, and C. N. Haas, "Dose-response models for inhalation of Bacillus anthracis spores: Interspecies comparisons," Risk Anal., vol. 28, no. 4, pp. 1115-1124, 2008.
19. C. N. Haas and J. B. Rose, "Reconciliation of microbial risk models and outbreak epidemiology: The case of the Milwaukee outbreak," in Proc. 1994 AWWA Ann. Conf., 1994, pp. 517-523.
20. A. M. Weinberg, "Science and trans-science," Minerva, vol. 10, no. 2, pp. 209-222, 1972.